Structure–Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors
2021
We identified nitazoxanide (NTZ) as a moderate STAT3 pathway inhibitor through immunoblot analysis and a cell-based IL-6/JAK/STAT3 pathway activation assay. A series of thiazolide derivatives were ...
-
Correction
-
Source
-
Cite
-
Save
37
References
0
Citations
NaN
KQI